March 18, 2023

1 min learn

ADD TOPIC TO EMAIL ALERTS

Obtain an e-mail when new articles are posted on

Please present your e-mail tackle to obtain an e-mail when new articles are posted on .

” data-action=subscribe>
Subscribe

We had been unable to course of your request. Please strive once more later. Should you proceed to have this challenge please contact customerservice@slackinc.com.

Again to Healio

Edith P. Mitchell, MD, MACP, FCCP, FRCP (London), has been named enterprise vice chairman for most cancers disparities at Jefferson Well being’s Sidney Kimmel Most cancers Heart.

On this new position, Mitchell might be liable for growing and coordinating operations for most cancers care disparities throughout Jefferson.

She’s going to oversee a staff centered on most cancers care high quality and cost-effectiveness, in addition to patient-oriented outcomes. She additionally will give attention to figuring out and eliminating boundaries to care, significantly these associated to socioeconomic, racial or ethnic disparities and social determinants of well being.

Edith P. Mitchell

“Dr. Mitchell has had a unprecedented profession devoted to eliminating well being disparities affecting too many people and communities within the Philadelphia space and past,” Andrew Chapman, DO, director of Sidney Kimmel Most cancers Heart and govt vice chairman of oncology companies at Jefferson Well being, stated in a press launch. “Her work with group well being suppliers has elevated minority participation in scientific trials and he or she has introduced most cancers screening to neighborhoods missing entry to preventive care. Dr. Mitchell’s experience and devotion to well being fairness is invaluable to the Sidney Kimmel Most cancers Heart in our dedication to ship high-quality most cancers care throughout the area.”

Mitchell additionally serves as director of Heart to Eradicate Most cancers Disparities and scientific professor of drugs and medical oncology at Jefferson Well being’s Sidney Kimmel Most cancers Heart. She joined Jefferson in 1995.

Her analysis has centered on boundaries to scientific trial participation, in addition to novel drug analysis and new therapy regimens for sufferers with breast most cancers or gastrointestinal cancers.

ADD TOPIC TO EMAIL ALERTS

Obtain an e-mail when new articles are posted on

Please present your e-mail tackle to obtain an e-mail when new articles are posted on .

” data-action=subscribe>
Subscribe

We had been unable to course of your request. Please strive once more later. Should you proceed to have this challenge please contact customerservice@slackinc.com.

Again to Healio

Race and Drugs